JANE STREET GROUP, LLC - REDHILL BIOPHARMA LTD ownership

REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 58 filers reported holding REDHILL BIOPHARMA LTD in Q2 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of REDHILL BIOPHARMA LTD
ValueSharesWeighting
Q4 2022$2,015
-77.6%
14,364
+33.4%
0.00%
Q2 2022$9,000
-90.9%
10,770
-72.4%
0.00%
Q1 2022$99,000
-56.8%
39,075
-56.7%
0.00%
Q4 2021$229,000
-78.1%
90,276
-60.5%
0.00%
Q3 2021$1,044,000
+635.2%
228,399
+1002.0%
0.00%
Q2 2021$142,000
+49.5%
20,725
+59.4%
0.00%
Q1 2021$95,0000.0%13,000
-38.2%
0.00%
Q1 2020$95,000
-75.3%
21,036
-64.6%
0.00%
-100.0%
Q2 2019$384,000
+39.1%
59,405
+108.1%
0.00%0.0%
Q1 2017$276,00028,5480.00%
Other shareholders
REDHILL BIOPHARMA LTD shareholders Q2 2021
NameSharesValueWeighting ↓
GAGNON SECURITIES LLC 367,346$926,0000.15%
DISCIPLINED GROWTH INVESTORS INC /MN 1,950,002$4,914,0000.11%
Claret Asset Management Corp 95,430$240,0000.05%
Annandale Capital, LLC 43,532$110,0000.04%
ARK Investment Management 861,798$2,172,0000.01%
Virtu Financial LLC 26,864$68,0000.01%
Ancora Advisors LLC 82,048$207,0000.01%
OSAIC HOLDINGS, INC. 4,600$1,372,0000.00%
TWO SIGMA SECURITIES, LLC 25,499$64,0000.00%
ATTICUS WEALTH MANAGEMENT, LLC 2,425$6,0000.00%
View complete list of REDHILL BIOPHARMA LTD shareholders